Navigation Links
Medivation's Dimebon(TM) Significantly Improved Thinking and Memory in Alzheimer's Disease Patients Over One Year
Date:4/17/2008

with AD and one of two endpoints the U.S. Food and Drug Administration (FDA) has used to approve all currently marketed drugs for mild-to-moderate AD. In the study, ADAS-cog was assessed at the beginning of the study and at weeks 12, 26, 39 and 52.

Results showed that Dimebon-treated patients were significantly improved compared with placebo on 9 of the 11 ADAS-cog subdomains after one year of treatment. Benefits were observed in memory (word recall, p=0.04; word recognition, p=0.03; remembering instructions, p=0.10); orientation (p= 0.01); constructional praxis (the ability to copy simple drawings or patterns, p=0.005) and ideational praxis (the ability to perform a familiar but complex sequence of actions, p=0.006); and language (following commands, p<0.0001; naming objects, p<0.0001; word finding, p=0.005; comprehension, p=0.15; overall language, p=0.0002).

"We have recently presented a number of different findings from our first pivotal trial of Dimebon at scientific conferences, demonstrating that this investigational drug has a beneficial impact on the key aspects of Alzheimer's disease -- from behavioral symptoms to thinking and memory problems to impairments in daily function," said Lynn Seely, M.D., chief medical officer of Medivation. "Medivation is committed to rapidly developing Dimebon as a treatment for mild-to-moderate Alzheimer's disease to make it available to the millions of people who suffer from this increasingly prevalent disease, for which new treatment options are desperately needed."

Dimebon Showed Statistically Significant Benefit Versus Placebo on All Key Efficacy Endpoints

Medivation previously announced efficacy and safety results from the pivotal, 12-month, double-blind, placebo-controlled trial of Dimebon in 183 patients with mild-to-moderate AD. Dimebon improved the clinical course of Alzheimer's disease patients by causing statistically significant improvements over placebo in each of the five primary aspe
'/>"/>

SOURCE Medivation, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Medivations Dimebon(TM) Significantly Improved Daily Function in Alzheimers Disease Patients, Resulting in Reduced Need for Caregiver Assistance
2. Medivations Dimebon(TM) Stabilizes Behavioral Symptoms in Alzheimers Disease Patients, Resulting in Reduced Caregiver Distress
3. Data Presented at the American Academy of Neurology Show XP13512/GSK1838262 Significantly Improved Symptoms of Moderate-to-Severe Primary Restless Legs Syndrome
4. Data Presented at AAN Show That Lacosamide Significantly Reduced Pain and was Generally Well Tolerated in Patients With Diabetic Neuropathic Pain
5. Orqis(R) Medicals Cancion(R) System Significantly Increases Cardiac Performance
6. CV Therapeutics Anti-Ischemic Therapy Ranexa(R) Significantly Reduces Cardiac Chest Pain Symptoms and Recurrent Ischemia in MERLIN-TIMI 36 Patients With Angina
7. Perioperative Eloxatin(R)-Based Regimen Significantly Reduced the Risk of Relapse Versus Surgery Alone in Eligible Colorectal Cancer Patients with Initially Resectable Liver Metastases
8. Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs
9. Everolimus (RAD001) Significantly Extends Progression-Free Survival in Advanced Kidney Cancer Patients After Failure of Other Targeted Therapy
10. Phase I and Phase I/II DCVax(R)-Brain Data Continues to Show Significantly Improved Survival Rates for Brain Cancer Patients
11. New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... 2015 Kewaunee Scientific Corporation (Nasdaq: KEQU ... quarterly cash dividend of twelve cents per outstanding share, ... at the close of business on June 12, 2015. ... in 1906, Kewaunee Scientific Corporation is a recognized global ... healthcare, and technical furniture products. Products include steel, wood, ...
(Date:6/2/2015)... REPORT HIGHLIGHTS The global market for ... This market is expected to increase from more than $4.1 ... compound annual growth rate (CAGR) of 13.6% over the five-year ... An in-depth analysis of the global markets and ... from 2013, estimates for 2014, and projections of compounds annual ...
(Date:6/2/2015)... , June 02, 2015 Research ... addition of Jain PharmaBiotech,s new report "Drug ... Markets and Companies" to their offering. ... system (CNS) is a challenge in the treatment ... into the CNS or administered systematically (e.g., by ...
Breaking Medicine Technology:Global Markets and Technologies for Medical Lasers 2Global Drug Delivery in Central Nervous System Diseases Report 2015-2024 - Technologies, Markets and Companies 2Global Drug Delivery in Central Nervous System Diseases Report 2015-2024 - Technologies, Markets and Companies 3
... Genmab A/S (OMX:,GEN) announced today a Phase ... of ofatumumab (HuMax-CD20(R)) in rheumatoid arthritis (RA),patients, stable ... which,will consist of two parts and include approximately ... addition of a subcutaneous method of administrating ofatumumab ...
... and benefits of early treatment ... with liraglutide versus glimepiride, SAN FRANCISCO, June ... the American Diabetes Association (ADA),demonstrated that once-daily liraglutide when taken ... with type 2 diabetes, as compared to glimepiride, a widely ...
Cached Medicine Technology:Genmab A/S - Company Announcement Ofatumumab in Subcutaneous Study in Rheumatoid Arthritis Summary: Subcutaneous Administration of Ofatumumab Investigated in Phase I/II Study 2Genmab A/S - Company Announcement Ofatumumab in Subcutaneous Study in Rheumatoid Arthritis Summary: Subcutaneous Administration of Ofatumumab Investigated in Phase I/II Study 3Video: Clinical Study Shows Liraglutide Reduced Blood Sugar, Weight, and Blood Pressure in Patients with Type 2 Diabetes 2Video: Clinical Study Shows Liraglutide Reduced Blood Sugar, Weight, and Blood Pressure in Patients with Type 2 Diabetes 3Video: Clinical Study Shows Liraglutide Reduced Blood Sugar, Weight, and Blood Pressure in Patients with Type 2 Diabetes 4
(Date:6/3/2015)... Veatch Consulting Services is excited to announce their ... business in April 2006, they have made it a ... Each and every year they have worked diligently in ... say that they are off to a great start ... this year is the Customer Review site veatchconsultingreviews.weebly.com. At ...
(Date:6/3/2015)... Israel (PRWEB) June 03, 2015 ... emergency mass-notification, multi-channel solutions, reported of its "behind-the-scenes" ... the past few months. Since March this year, ... has been inflicting the South-American country, putting millions ... ash and gas into the atmosphere. "evigilo's technology, ...
(Date:6/2/2015)... (PRWEB) June 03, 2015 BALTIMORE, Md. ... to write a book about wellness after being diagnosed ... she believes that through lifestyle changes which enhance health, ... In “ A Wellspring for Wellness ,” she ... diseases. , This book provides an overview of ...
(Date:6/2/2015)... The organic cotton market is again growing according ... conducted by Textile Exchange, an international nonprofit organization committed ... today, encompasses extensive data about organic cotton from seed ... takes the opportunity to celebrate those who are building ... last several years have been complicated for the organic ...
(Date:6/2/2015)... Kan. (PRWEB) June 02, 2015 Concorde ... Bell as President and COO. Bell will manage day-to-day ... , “I’m looking forward to the opportunity to help ... students,” Bell said. “I joined Concorde in part due ... Institute that highlighted Concorde colleges in Memphis and Portland.” ...
Breaking Medicine News(10 mins):Health News:Veatch Consulting Services Is Breaking New Ground in Customer Satisfaction 2Health News:Veatch Consulting Services Is Breaking New Ground in Customer Satisfaction 3Health News:Thousands of Lives Saved, Millions Protected in Chile 2Health News:New book offers holistic approach in living with autoimmune diseases 2Health News:New book offers holistic approach in living with autoimmune diseases 3Health News:Organic Cotton Market Sees 10% Growth Following Three Years of Decline 2Health News:Organic Cotton Market Sees 10% Growth Following Three Years of Decline 3Health News:Organic Cotton Market Sees 10% Growth Following Three Years of Decline 4Health News:Organic Cotton Market Sees 10% Growth Following Three Years of Decline 5Health News:Concorde Career Colleges Announces New President and COO 2
... poultry made its way to the food chain via the ... strain// of bird flu in early February this year. ... almost 850 tons of turkey had to pass through the ... the interim period between outbreak of the avian influenza and ...
... Haikerwal, today urged more Australians to donate blood and donate ... ,Dr Haikerwal said the AMA strongly supports the ... designed to raise the number of Australian blood donors and ... year. ,“Blood donors save lives,” Dr Haikerwal ...
... are varied reactions to the U.S panel hearing ... , The Senate Health, Education, Labor and ... Food and Drug Administration legal authority to approve alternative ... Yet it has drawn both brickbats and ...
... article published in the prestigious international journal 'The Lancet' by ... Darwin// has revealed a breakthrough in the battle to treat ... the worlds population. ,There are two major strains ... attention focuses on the more virulent P. falciparum, vivax malaria ...
... in a duck farm in Chonan, in central South Korea. ... bird flu on Thursday//. The cause was identified as "highly ... bird flu outbreak since November reported in South Korea. H5N1 ... Korea. ,The culling of over 55,000 poultry will ...
... According to statistics over one lac people Indians are diagnosed ... die as they do not get timely treatment. ... Check-up package in connection with World Kidney Day-2007. The camp ... and urine analysis for random glucose and creatinine. ...
Cached Medicine News:Health News:Generic Biologics – U.S Panel Hearing Draws Mixed Response 2Health News:Researchers Discover Breakthrough in Malaria Treatment 2
Spectra 3000RS & Spectra 3000RSP are very precise instruments. They have a metal base structure, durable parts for long life use, and they are very easy to use and maintain....
... Series Spectrophotometer is truly ... UV-VIS instrumentation. The latest ... into a radically new ... and performance unprecedented in ...
... the user to quickly and accurately count bacteria ... counting or manual counting. An optional 1.5X auxiliary ... to 3.0X. The adjustable focusing rod allows the ... The lens also rotates a full 360 for ...
The Accucount 2000 is designed to automatically count microscopic objects in a field displaying totals on a highly visible digital readout....
Medicine Products: